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Abstract: Bioactivity-guided fractionation of Corydalis yanhusuo has resulted in the 
isolation of eight known isoquinoline alkaloids - tetrahydropalmatine, isocorypalmine, 
stylopine, corydaline, columbamine, coptisin, 13-methylpalmatine, and dehydro-
corybulbine. The tertiary alkaloids were further analyzed by chiral HPLC to determine the 
ratios of d-and l-isomers. The isolated compounds were screened for their binding 
affinities at the dopamine D1 receptor. Isocorypalmine had the highest affinity (Ki = 83 
nM). The structure-affinity relationships of these alkaloids are discussed. 









Alcohol and drug abuse are major social and medical problems that impose a significant burden on 
society [1-2]. Because of the complexity of drug dependence and the lack of effective remedy, 
especially for relapse, the development of pharmacotherapy for its treatment has been a serious 
challenge [3]. Despite a great deal of effort in developing effective therapies, only few medications 
have been approved by the U.S. Food and Drug Administration [2, 4]. These medications have shown 
only limited efficacy, serious side effects and poor compliance in patients [5-8], therefore, an 
alternative approach, the systematic evaluation of traditional herbal medicines, may provide new drug 
candidates for the treatment of alcohol and drug abuse. Chinese herbal medicines have been used 
historically in the treatment of alcohol and drug abuse [4, 9]. Many are still prescribed in China and 
Southeast Asia for this purpose, and their clinical efficacy of some medications has recently been 
documented [10]. NPI-025 [11] is a herbal formula used clinically to treat opioid addiction in Hong 
Kong. It is composed of five Chinese herbs, including Rhizoma Corydalis (Yan Hu Suo), Rhizoma Et 
Radix Notopterygh (Qiang Huo), Ramulus Uncariae Cum Uncis (Gou Teng), Rhizoma Chuanxiong 
(Chuan Xiong) and Radix Aconiti Lateralis Preparata (Fu Zi, treated with hot strong base to reduce 
toxicity) [12-13]. 
The dried tuber of Corydalis yanhusuo (Papaveraceae) is one of key ingredients in NPI-025. C. 
yanhusuo has been used traditionally to promote blood circulation, reinforce vital energy, and alleviate 
pain such as headache, chest pain, epigastric pain, abdominal pain, backache, arthralgia, 
dysmenorrheal pain, or trauma, and is officially listed in the Chinese Pharmacopoeia [14-16]. Previous 
phytochemical and pharmacological studies have identified several alkaloids as the active secondary 
metabolites of the plant [16]. dl-Tetrahydropalmatine (dl-THP), one of the major active alkaloids, has 
been found to be a neuroactive alkaloid [17-19]. It has been listed in the Chinese Pharmacopoeia since 
1977 as an analgesic with sedative and hypnotic effects. Recent studies have demonstrated that l-THP 
inhibits opiate tolerance and withdrawal syndromes in rats [20-21]. It was also reported that l-THP 
significantly inhibits cocaine- or methamphetamine-induced conditioned place preference [22-23]. In 
addition, l-THP inhibited cocaine-triggered reinstatement [24] and the rewarding effects of cocaine in 
rats as measured by cocaine self-administration [24-25] and intracranial self-stimulation [25]. In a 
recent double-blind clinical trial in China, Yang et al. [10] found that treatment of 119 heroin-only 
dependent in-patients with l-THP (60 mg orally twice a day) for one month significantly reduced 
heroin craving and withdrawal symptoms. These findings suggest that l-THP could be an excellent 
drug candidate for treatment of drug addition. 
As part of our ongoing investigation of alternative therapies for substance addiction [11, 26], we 
initiated a comprehensive fractionation study guided by dopamine receptor binding assays in an 
attempt to find new dopamine receptor agonists or antagonists from C. yanhusuo. Herein we report the 
isolation of eight isoquinoline alkaloids, their D1 receptor binding activities and their stereochemistry 
by chiral HPLC method. 
 
 




Results and Discussion 
The 70% aqueous acetone extract of C. yanhusuo were subjected to sequential extraction with 
hexane, ethyl acetate, butanol, methanol and water. In our initial biological study as shown in Table 1, 
the hexane, ethyl acetate, butanol and methanol extracts at 50 mg/mL showed moderate binding 
activity at rat dopamine D1 receptor (rD1R) stably expressed in CHO cells, compared with the positive 
control SKF82958 [27] (10 μM), while the water extract had no activity. 
 
Table 1. Displacement of [3H]SCH 23390 binding to membranes of CHO cells stably 
expressing the rD1R. 
Sample I.D. Concentration Displaced [3H]SCH 23390 
hexane extract 50 mg/mL 100% 
AcOEt extract 50 mg/mL 96% 
BuOH extract 50 mg/mL 97% 
MeOH extract 50 mg/mL 88% 
water extract 50 mg/mL -2% 
SKF82958 10 μM 99% 
The hexane, ethyl acetate, butanol and methanol extracts were chromatographed on silica gel 
columns to give eight known isoquinoline alkaloids (Figure 1), tetrahydropalmatine (1) [28], 
isocorypalmine (2) [28], stylopine (3) [29], corydaline (4) [30], columbamine (5) [31], coptisin (6) 
[31], 13-methylpalmatine (7) [31] and dehydrocorybulbine (8) [32]. The tertiary alkaloids 1, 2 and 3 
have a chiral center at the C-14 position, and may consist of two optical isomers. Compound 4 has two 
chiral centers at the C-13 and C-14 positions, and the 1H-NMR spectrum of 4 displayed the H-14 
methine as a doublet at δ 3.68 (J = 2.7 Hz), indicating the protons at H-13 and H-14 are cis oriented 
[30]. Following the reported method [17-18], compounds 1, 2, 3 and 4 were analyzed by chiral HPLC. 
As shown in Table 2, the ratios of d- and l-isomers of 1, 3 and 4 are 3:1, 1:10 and 10:1, respectively, 
while 2 gave only one peak in its chiral HPLC (Figure 2). In order to further confirm the 
stereochemistry of 2, l-2 was synthesized by demethylation of l-THP (l-1) with BBr3 in CH2Cl2 
(Scheme 1). The reaction time is critical for a good yield. After one hour, the main product was l-2, 
while after 2 h the main product was found to be the l-scoulerine (9). Compounds l-2 and 9 were 
difficult to be separated by silica gel column chromatography. However, based on its solubility, l-2 can 
be readily purified by recrystalization from methanol. Following the same synthetic procedure, dl-2 
was also prepared from dl-THP (dl-1). Comparison of the chiral HPLC chromatogram of 2 with those 
of l-2 and dl-2 (Figure 2) confirmed that compound 2 was the l-enantiomer. 
Scheme 1. Synthesis of l-2 from l-1. 
 




Figure 1. Isoquinoline alkaloids isolated from C. yanhusuo. 
 
Figure 2. Chromatograms obtained from chiral separation of 2 (A), synthetic l-2 (B) and dl-2 (C). 
 
HPLC conditions: Waters 1525 Binary HPLC Pump; Waters 2487 Dual λ Absorbance 
Detector; Chiralcel OD Column (4.6 x 250 mm); 50% EtOH as mobile phase; Wavelength, 
230 nm; Sample concentration, 0.5 mg/mL; Injection volume, 5 µL 
 
The isolated alkaloids were tested for dopamine receptor binding as reported previously [11]. 
Compounds 1, 2, 3, 5, 7 and 8 inhibited [3H]SCH 23390 binding to human D1 receptor (hD1R) by more 
than 50% at 10 μM, and their binding affinities were determined (Table 2). The l-enantiomer of 1 (l-




THP) has a D1 affinity of 94 nM while the 3:1 mixture of the d- and l-enantiomers 1 has a much 
weaker affinity of 1.3 μM. It has been reported that l-1 has analgesic activity with a more potent 
tranquilizing effect than the d isomer [19, 33]. Previous studies have demonstrated that l-1 acts on 
dopamine receptors, but d-THP does not [34, 35]. Compound l-1 is a non-subtype selective antagonist 
at dopamine receptors[35-37]. 
Of the isolated alkaloids, compound 2 has the highest D1 affinity with a Ki of 83 nM, comparable in 
potency to l-1. Jin et al. [35, 37] reported that l-THP derivatives with one hydroxyl group at C-2 and 
two hydroxyl groups at C-2 and C-9 or C-2 and C-10 were more potent at dopamine receptors than l-1. 
On the other hand, Guo et al. [38] reported that l-1 was readily metabolized to desmethylated l-THPs 
in rats. 
Table 2. Binding affinities of the purified alkaloids for the [3H] SCH 23390 labeled the 
hD1R in transiently transfected HEK-T cells. 
Compound ratio of d:l-isomers Ki (nM)a  
1 3:1 1,293 ± 71 
2 0:1 83 ± 5 
3 1:10 1,043 ± 66 
4 10:1 >10,000 
5 - 4,112 ± 274 
6 - >10,000 
7 - 3,867 ± 235 
8 - 1,836 ± 200 
l-THP 0:1 94 ± 9 
a Each value represents the mean ± SEM of three independent experiments performed in duplicate 
As shown in Table 2, the quaternary alkaloids (5 and 6) exhibited weaker binding affinities than the 
corresponding tertiary alkaloids (2 and 3). Comparison of the binding affinities of 7 and 8 with that of 
5 revealed that the methyl group at C-13 did not affect the overall binding activity at the D1 receptor. 
In order to obtain enough pure alkaloids for biological and pharmacological studies, another larger 
batch of crude extract of C. yanhusuo was fractionated. Compounds 1, 2, 3 and 4 were isolated from 
the new extract. Subsequent chiral HPLC analysis showed that the ratios of d- and l-enantiomers in 
newly isolated 2 and 3 remained the same as those of previous isolated 2 and 3, while the ratios in both 
1 and 4 were changed to 1:1. The changes of these components in different extracts of C. yanhusuo 
indicated that different geographical regions, seasons of harvest, storage, or extraction conditions 
could affect the chemical composition significantly. As evidenced in our case, quality control of the 
active optical isomers will be very important for future biological, pharmacological, and clinical 
studies of C. yanhusuo. 
Conclusions 
The mesolimbic dopaminergic system has been shown to play an important role in drug abuse [39]. 
Compounds targeted to these dopamine receptors can provide a rational treatment of drug abuse [40]. 
The stereochemistry of l-isocorypalmine (2) and the d/l ratio of 1, 3, and 4, were established 
unambiguously by using a chiral HPLC method along with concise chemical synthesis. In addition, 




this convenient and effective synthesis for selective cleavage the methoxy group at C-2 position 
allows the preparation of l-isocorypalmine in a large amount from readily available l- 
tetrahydropalmatine for animal study. The present study demonstrates that isoquinoline alkaloids are 
the principal constituents for the binding activities of C. yanhusuo extracts at the dopamine D1 
receptor. l-Isocorypalmine (2) showed the highest affinity and is a promising drug candidate. This 
study provides an important pharmacological basis to support the traditional use of C. yanhusuo in the 
treatment of heroin addiction in China. Its complete pharmacological characterization is under 






The NMR spectra were recorded on a Varian VXR300 spectrometer with TMS as the internal 
standard. EI-MS spectra were obtained on a HP5972 Series Mass spectrometer. HPLC was performed 
on a Waters (Milford, MA, USA) system comprised of a 1525 Binary HPLC Pump equipped with a 
Waters 2487 Dual λ Absorbance Detector set at a wavelength of 230 nm, a model 7725i sample 
injector equipped with a 5 μL loop and a Waters Breeze software package for data collection. 
Compounds were separated on a Chiralcel OD Column (4.6 x 250 mm). The mobile phase was 50:50 
(v/v) ethanol–water. All analysis was performed at a flow-rate of 0.5 mL/min with detection at 230 
nm. The mobile phase was filtered through a 0.45 μm filter and degassed. Separations were performed 
at room temperature. Silica gel (Fisher Scientific, USA) were used for column chromatography. TLC 




The dried tubers of C. yanhusuo were collected from Qianxian Town, Dongyang District, Zhejiang 
province, P.R. China in May, 2005. Its botanical identification was confirmed by Dr. Shilin Chen, the 
Institute of Medicinal Plant Development (IMPLAD), Beijing, P.R. China. A voucher specimen has 
been deposited in the IMPLAD, Beijing, P.R. China.  
 
Extraction and isolation 
 
The dried tubers of C. yanhusuo (30 kg) were powdered and extracted with 70% aqueous acetone 
for three times at room temperature, and the solution was evaporated under reduced pressure to give a 
residue (2.2 kg). The 70% aqueous acetone extract (200 g) was subjected to sequential extraction with 
hexane, ethyl acetate, butanol, methanol and water. The combined part (3 g) of the above hexane, ethyl 
acetate and butanol extracts was chromatographed over silica gel (100 g) using CH2Cl2 with increasing 
amounts of MeOH (10:1, 5:1, 3:1, 1:1 and 1:2) to give five fractions A-E. Fraction A was further 
purified by silica gel column, with a gradient of hexane and acetone to afford 1 (20 mg), 2 (15 mg), 3 
(10 mg) and 4 (15 mg). Fraction B was chromatographed over silica gel column with a gradient of 
CH2Cl2 and MeOH to afford 5 (10 mg), 7 (250 mg) and 8 (3 mg). Fraction C was purified by silica gel 




column, with a gradient of CH2Cl2 and MeOH, to afford 6 (8 mg). In a similar manner, the MeOH 
extract (8 g) was separated by silica gel column chromatography using CH2Cl2 with increasing 
amounts of MeOH to give 5 (20 mg) and 7 (500 mg).  
 
Synthesis of l-isocorypalmine (2) 
 
To a stirred CH2Cl2 solution (10 mL) of l-tetrahydropalmatine (l-1, 355 mg, 1.0 mmol), BBr3 
solution (1 mM in CH2Cl2, 5 mL) was added. The reaction was stirred at -78 ºC for 1 h, and then was 
warmed to room temperature. The mixture was diluted with CH2Cl2 (50 mL) and washed with excess 
saturated NaHCO3. The organic extract was dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was purified by silica gel column chromatography (CH2Cl2 and MeOH, 20:1), 
followed by recrystallization in MeOH, to give l-2 (150 mg) and l-scoulerine (9, 40 mg). 
 
Competitive inhibition of [3H] SCH23390 binding to dopamineD1 receptor  
 
Chinese hamster ovary cells (CHO) stably transfected with HA-tagged rat D1 dopamine receptor 
(rD1R) were grown in 100-mm culture dishes in Dulbecco's modified Eagle's medium F12 HAM 
supplemented with 10% fetal calf serum, 0.1 mg/mL hygromycin B, 100 units/mL penicillin and 100 
µg/mL streptomycin in a humidified atmosphere consisting of 5% CO2 and 95% air at 37°C. Binding 
to membranes prepared from CHO cells stably transfected with the rD1R was conducted with 
[3H]SCH23390 (0.2 nM) in 50mMTris-HCl buffer containing 1 mM EGTA (pH 7.4) (TE buffer) at 
room temperature for 1 h in duplicate. Nonspecific binding was defined as binding in the presence of 
Fluphenazine (10 μM). The purified compounds showing more than 50% displacement of 
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